Barclays
OBCI

Barclays’s Ocean Bio-Chem Inc OBCI Stock Holding History

Barclays’s Portfolio OBCI Stock Details OBCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-578
Closed -$5K – 5474
2022
Q1 		$5K Sell
578
-11
-2% -$98 ﹤0.01% 4709
2021
Q4 		$5K Sell
589
-877
-60% -$8.59K ﹤0.01% 4027
2021
Q3 		$14K Hold
1,466
– – ﹤0.01% 4475
2021
Q2 		$18K Sell
1,466
-1,311
-47% -$16.7K ﹤0.01% 4527
2021
Q1 		$34K Sell
2,777
-211
-7% -$2.53K ﹤0.01% 4282
2020
Q4 		$40K Hold
2,988
– – ﹤0.01% 4508
2020
Q3 		$43K Buy
+2,988
New +$45.2K ﹤0.01% 4676
2019
Q4 		– Sell
-5
Closed – – 7016
2019
Q3 		$0 Buy
+5
New +$17 ﹤0.01% 7307
2018
Q4 		– Sell
-4
Closed – – 7520
2018
Q3 		$0 Buy
+4
New +$16 ﹤0.01% 7517

Other funds holding OBCI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Barclays's OBCI Position: Q2 2022 in Review

Barclays sold out of Ocean Bio-Chem Inc (OBCI) in Q2 2022, closing a stake of 578 shares — an estimated $5K sold.

Barclays first reported a position in OBCI in Q3 2018 and held it in 9 quarters. The position peaked at $43K in Q3 2020. 17 funds tracked by Wall St. Rank hold OBCI as of Q2 2022.

  • Barclays reported no remaining Ocean Bio-Chem Inc position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 578 Ocean Bio-Chem Inc shares in Q2 2022, an estimated $5K.
  • Barclays first reported a position in Ocean Bio-Chem Inc in Q3 2018 and held it in 9 quarters.
  • Barclays's Ocean Bio-Chem Inc position peaked at $43K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.